Answer
Women should not breastfeed during treatment with Glivec (imatinib) and for at least 15 days after stopping treatment, because the effects of low-dose imatinib exposure on infants are unknown.
Sources for this answer
- GLIVEC film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 41Document updated
Sources checked